Private telehealth: weight, hormones, sexual health, sleep, and mental wellbeing.
Explore careA licensed provider evaluates which weight-care path—if any—is appropriate for you. Availability depends on your medical history, state law, pharmacy access, product status, and the licensed provider’s independent judgment.
Prescription required. An independent licensed provider reviews your medical history and decides whether treatment is appropriate. Not everyone qualifies.
A useful weight-care conversation includes the parts that happen away from a scale: appetite patterns, sleep, energy, prior treatment, side effects, family history, pregnancy plans, and what feels sustainable in real life.
A clinical noteThe goal is not to match everyone to a medication. It is to identify whether remote care fits, what information is still needed, and which options may be reasonable to discuss.
Not routinely available or guaranteed. A state-licensed compounding pharmacy may prepare a medication for an identified patient only after a valid prescription and when current federal and state requirements are satisfied.
Semaglutide · Weekly injection
Not FDA-approved · Rx only · lawful patient-specific availability variesA compounded GLP-1 option may be discussed only when a licensed provider identifies and documents an appropriate patient-specific basis and lawful pharmacy access exists.
Tirzepatide · Weekly injection
Not FDA-approved · Rx only · lawful patient-specific availability variesA compounded GLP-1/GIP option may be discussed only when a licensed provider identifies and documents an appropriate patient-specific basis and lawful pharmacy access exists.
Brand-name medications retain their approved labeling, manufacturer safety information, pharmacy availability, and separate pharmacy cost.
Semaglutide · Weekly injection or oral tablet
FDA-approved for chronic weight management in eligible patientsA brand-name semaglutide option a licensed provider may consider based on clinical history, eligibility, availability, and cost.
Tirzepatide · Weekly injection
FDA-approved for chronic weight management in eligible patientsA brand-name tirzepatide option a licensed provider may consider after reviewing medical history, goals, contraindications, and access.
Some FDA-approved diabetes medications may be prescribed off-label for weight management at a licensed provider’s discretion. Approval, access, or suitability is never guaranteed.
Semaglutide · Weekly injection
FDA-approved for type 2 diabetes—not for weight lossA licensed provider may prescribe an approved medication for an off-label use when clinically appropriate and legally permitted.
Tirzepatide · Weekly injection
FDA-approved for type 2 diabetes—not for weight lossA licensed provider may discuss off-label use only after a patient-specific clinical assessment and review of appropriate alternatives.
Review warnings, contraindications, adverse effects, emergency symptoms, compounded-drug limitations, and official product labels before care.
